Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Charles Rietz"'
Autor:
Sherry Koleszar, Stephen E. Jones, Michael Grant, George N. Peters, Timothy George, Michael Savin, Joanne L. Blum, John Pippen, Daniel A. Savino, Robert Kirby, Gaby Ethington, Steven Paulson, Sally M. Knox, Robert G. Mennel, Ronald Kerr, Douglas Orr, Barry Don Brooks, Gary D. Clark, Marvin J. Stone, Claude Denham, Charles Rietz
Publikováno v:
Clinical breast cancer. 3(2)
This prospective clinical trial was designed to assess the impact of adjuvant chemotherapy in women with rapidly proliferating node-negative breast cancer. This group has been predicted to have a 5-year disease-free survival (DFS) of 70% without adju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8971766f493d6f22119ec1e6536319
https://pubmed.ncbi.nlm.nih.gov/12123539
https://pubmed.ncbi.nlm.nih.gov/12123539
Autor:
Michael Grant, Lloyd W. Kitchens, Timothy George, George N. Peters, Steven Paulson, Sherry Koleszar, Charles Rietz, John Pippen, Robert G. Mennel, Joseph A. Kuhn, Joanne L. Blum, Harold Cheek, Ronald Kerr, Charles White, Barry Don Brooks, Stephen E. Jones, Daniel A. Savino, Zelig H. Lieberman, Ronald C. Jones, Marvin J. Stone, Gary D. Clark, Claude Denham, Robert Kirby, Sally M. Knox, Michael Savin, Barry Cooper, Gaby Ethington
Publikováno v:
Clinical breast cancer. 1(4)
This study was designed to compare outcome in terms of disease-free survival (DFS) in women with histologically negative axillary lymph nodes and documented low proliferative rate cancer to other well-defined prognostic factors including type of adju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9da709d463dc4383af24c960eab7ac50
https://pubmed.ncbi.nlm.nih.gov/11899353
https://pubmed.ncbi.nlm.nih.gov/11899353